ImageneBio Inc. (IMA)
NasdaqCM: IMA
· リアルタイム株価 · USD
5.75
+0.13 (2.31%)
終値時点: Aug 12, 2026, 3:33 PM
ImageneBio Inc. (IMA) Stock Price, Analysis & Data
2.31% (1D)
IMAについて
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its nam...
セクター Healthcare
IPO日 Mar 26, 2021
従業員数 18
上場取引所 NasdaqCM
ティッカー IMA
ウェブサイト https://www.inmagenebio.com
決算サプライズ
ImageneBioはAug 5, 2026に四半期決算を発表しました: